Covishield, Covaxin Receive Conditional Market Approval
Business Standard|January 28, 2022
The Drugs Controller General of India (DCGI) has given its nod to the market authorisation of two Covid vaccines — Bharat Biotech's Covaxin and Serum Institute of India's (SII's) Covishield --for use in the adult population, subject to certain conditions, said a Union health ministry statement on Thursday.
Ruchika Chitravanshi
Covishield, Covaxin Receive Conditional Market Approval

The approval was granted under the New Drugs and Clinical Trials Rules, 2019.

Both biotechnology companies will have to submit the data of the overseas ongoing clinical trials of their vaccines with due analysis every six months or as and when available, whichever is earlier.

The approval, DCGI said, reflects India's proactive and agile Covid management.

Even with market approval, all vaccinations within the country will have to be recorded on the COWIN platform.

This story is from the January 28, 2022 edition of Business Standard.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

This story is from the January 28, 2022 edition of Business Standard.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

MORE STORIES FROM BUSINESS STANDARDView All
Ukraine Warns Of WW3 If It Loses Against Russia
Business Standard

Ukraine Warns Of WW3 If It Loses Against Russia

The Prime minister of Ukraine said that there will be a "Third World War" if Ukraine loses its conflict with Russia, as he urged the US Congress to pass a long-stalled foreign aid bill.

time-read
1 min  |
April 19, 2024
VOTER PULSE, ONE STATION AT A TIME
Business Standard

VOTER PULSE, ONE STATION AT A TIME

On the tracks of political schism: Southern comfort for Opposition

time-read
4 mins  |
April 19, 2024
Good times ahead for UB as heatwave, IPL set the tone
Business Standard

Good times ahead for UB as heatwave, IPL set the tone

A cocktail of heatwave and upcoming cricketing events is expected to usher in the peak season for the country's largest beer maker, United Breweries.

time-read
2 mins  |
April 19, 2024
Business Standard

Invest with 5 to 7-year horizon to cope with economic cycles

Manufacturing has been in the limelight for some time due to the government's attempts to foster rapid growth in this segment of the economy.

time-read
2 mins  |
April 19, 2024
Business Standard

Good Q4, commentary perk up ICICI Lombard

ICICI Lombard General Insurance Company reported financial improvement and optimistic commentary in Q4FY24.

time-read
2 mins  |
April 19, 2024
Business Standard

NSE to launch derivatives on Nifty Next 50 this mth

Cash-settled derivatives contracts will expire on last Friday of expiry month

time-read
1 min  |
April 19, 2024
Business Standard

Markets extend losing streak for fourth straight session

Indices close in the red after volatile trade

time-read
2 mins  |
April 19, 2024
Business Standard

GQGEM Equity Funda hit among US investors

The actively managed fund's AUM tops $20 trillion

time-read
2 mins  |
April 19, 2024
Business Standard

Stock exchange to administer research analysts: Sebi

Enlisting with Sebi may re-register with the new administrative be mandatory

time-read
2 mins  |
April 19, 2024
Business Standard

Digital OPD a mixed bag with over 24 mn entries

The National Health Authority's (NHA) scan and share service has recorded more than 24 million digital out-patient department (OPD) registrations since its inception in September 2022, with Uttar Pradesh topping the list with over 7.8 million OPD tokens generated.

time-read
1 min  |
April 19, 2024